About this trial
The aim of this study is to assess outcomes of Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat
Reduced concavity of the femoral metaphysis proximal to the medial femoral condyle confirmed on MRI
Impingement of posterior horn of medial meniscus with the metaphysis of femur during full knee flexion confirmed arthroscopically
Disqualifiers
Active knee inflammation
Chondral injuries ICRS 3-4
Extraarticular reasons of pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat
Cyst or avascular changes within the femoral metaphysis adjacent to the planned localization of the procedure
Trial design
Single group
Treatments tested in this trial
Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment by the means of published technique (reference nr 1).
Procedure/SurgeryPosteromedial Tibiofemoral Incongruence (PMTFI) Treatment by the means of published technique (reference nr 1).
Treatment groups
Trial outcomes
Primary outcomes
Presence of pain in full knee flexion
Presence of pain in full knee flexion - deep squat: pain yes/no
Presence of pain in full knee flexion
Presence of pain in full knee flexion - deep squat: pain yes/no
Secondary outcomes
The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)
Min of 0 max of 87 points, higher scores mean a better outcome
The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)
Min of 0 max of 87 points, higher scores mean a better outcome
The functional assessment with the Knee injury and Osteoarthritis Outcome Score (KOOS)
Min of 0 max of 100 points, higher scores mean a better outcome
The functional assessment with the Knee injury and Osteoarthritis Outcome Score (KOOS)
Min of 0 max of 100 points, higher scores mean a better outcome
Sponsors and contacts
Click on the lead sponsor to view all of their trials.